Translating Pre-Clinical Research to Clinical Patient Care™

JMSACL Logo

EUROPE 2019

Help Us Reach Our Educational Support Goal of $40,000
Educational Grants supported in part by:

Scientific Committee

The Scientific Committee is assembled to review abstract submissions for the annual conference. This includes reviewing abstract submissions, suggesting plenary speakers, recruiting researchers to solicit abstracts for submission to the conference and identifying emerging topics of interest. The topics outlined below are the dominant topics addressed the MSACL conferences. MSACL encourages submissions in all areas of clinical mass spectrometry and evaluates abstracts that do not fall in the main topical categories listed below.

Chair

Elizabeth Want, PhD
Imperial College London

Financial Disclosures (past 24 months as of Feb 13, 2024) : none

Scientific Committee

Breath and VOC Analysis

Ilaria Belluomo, PhD (Lead)
Imperial College London

Financial Disclosures (past 24 months) : Not reported

Endocrinology

Graeme Eisenhofer, PhD (Lead)
Technische Universität Dresden

Financial Disclosures (past 24 months) : Not reported

Flaminia Fanelli, PhD
Dept. of Medical and Surgical Science, University of Bologna

Financial Disclosures (past 24 months) : Not reported

Tom Fiers, PhD
UZ Gent

Financial Disclosures (past 24 months) : Not reported

Brian Keevil, PhD
University Hospital of South Manchester

Financial Disclosures (past 24 months) : Not reported

Glycomics

Manfred Wuhrer, PhD, Prof. dr. (Lead)
Leiden University Medical Center

Financial Disclosures (past 24 months) : Not reported

Julien Boccard, PhD
University of Geneva

Financial Disclosures (past 24 months) : Not reported

Guinevere Lageveen-Kammeijer, PhD
University of Groningen

Financial Disclosures (past 24 months as of Apr 03, 2024)
Grants/Research Expenses: Astelas Pharma, Roche

Gordon Lauc, PhD
GlycanAge and Genos

Financial Disclosures (past 24 months) : Not reported

Dirk Lefeber, PhD
Radboudumc

Financial Disclosures (past 24 months) : Not reported

Imaging

Tiffany Porta, PhD (Lead)
Boehringer Ingelheim

Financial Disclosures (past 24 months) : Not reported

Isabelle Fournier, PhD
Laboratoire PRISM - Université de Lille

Financial Disclosures (past 24 months) : Not reported

Ron Heeren, PhD
Maastricht University

Financial Disclosures (past 24 months) : Not reported

Ólöf Gerður Ísberg, MSc, PhD
Vanderbilt University, MSACL Early Career Network

Financial Disclosures (past 24 months) : Not reported

Kristina Schwamborn, MD, PhD
Technical University of Munich

Financial Disclosures (past 24 months as of Feb 13, 2024)
Expenses/Honoraria: Bristol Myers Squibb (BMS)
Board/Committee: BMS, Merck, MSD, Roche, Janssen-Cilag, AstraZeneca

Raf van den Plas, PhD
TU Delft and Vanderbilt University

Financial Disclosures (past 24 months) : Not reported

Lipidomics

Anne Bendt, PhD (Lead)
Singapore Lipidomics Incubator (SLING), National University of Singapore

Financial Disclosures (past 24 months as of Feb 13, 2024) : none

Metabolomics

Oleg Mayboroda, PhD (Lead)
Leiden University Medical Center

Financial Disclosures (past 24 months) : Not reported

Warrick Dunn, PhD
University of Liverpool

Financial Disclosures (past 24 months) : Not reported

Julijana Ivanisevic, PhD
University of Lausanne

Financial Disclosures (past 24 months) : Not reported

Microbiology

Jean Armengaud, PhD
French Alternative Energies and Atomic Energy Commission Marcoule

Financial Disclosures (past 24 months) : Not reported

Simon Cameron, BSc PhD
Queen's University Belfast

Financial Disclosures (past 24 months) : Not reported

Edward Moore, PhD
University of Gothenberg, Sweden

Financial Disclosures (past 24 months) : Not reported

Stefan Zimmerman
University of Heidelberg

Financial Disclosures (past 24 months) : Not reported

Practical Training

Laura Owen (Lead)
Salford Royal NHS Foundation Trust & University of Manchester

Financial Disclosures (past 24 months) : Not reported

Grace van der Gugten, B.Sc. Chemistry (Lead)
Alberta Precision Laboratories

Financial Disclosures (past 24 months as of Feb 13, 2024) : none

Roland Geyer, Ph.D.
Thermo Fisher Diagnostics Switzerland

Financial Disclosures (past 24 months) : Not reported

Judy Stone, MT (ASCP), PhD, DABCC
Clinical Chemist (retired)

Financial Disclosures (past 24 months as of Feb 15, 2024) : none

Michael Wright
GSK

Financial Disclosures (past 24 months) : Not reported

Proteins & Proteomics

Christa Cobbaert, PhD (Lead)
LUMC

Financial Disclosures (past 24 months) : Not reported

Eva Hunyadi-Gulyas, PhD
Biological Research Centre

Financial Disclosures (past 24 months) : Not reported

Lars Melholt Rasmussen, MD, DMSc
Odense University Hospital, University of Southern Denmark

Financial Disclosures (past 24 months) : Not reported

Small Molecules / Tox / TDM

Jody van den Ouweland, PhD (Lead)
Canisius-Wilhelmina Hospital

Financial Disclosures (past 24 months) : Not reported

Marine Letertre, PhD
University of Nantes

Financial Disclosures (past 24 months) : Not reported

Michael Vogeser, Prof. Dr. med.
University Hospital, LMU Munich

Financial Disclosures (past 24 months as of Mar 05, 2024)
Expenses/Honoraria: Roche Diagnostics
Grants/Research Expenses: Roche Diagnostics
Board/Committee: Roche Diagnostics